Manali Deb Barma1, Indumathy Muthupandiyan1, Srinivasan Raj Samuel2, Bennett T Amaechi3. 1. Department of Public Health Dentistry, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, India. 2. Department of Public Health Dentistry, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, India. Electronic address: samuelrajsrinivasan@gmail.com. 3. Department of Comprehensive Dentistry, School of Dentistry, University of Texas Health San Antonio, USA.
Abstract
OBJECTIVE: Zinc is a potent antimicrobial against cariogenic bacteria and effective anti-plaque agent. The present study investigated the efficacy of zinc oxide nanoparticles (ZnO-NP) varnish to inhibit S. mutans growth, biofilm, acid production, and its antioxidant potential and cytotoxicity. DESIGN: Green synthesized ZnO-NP were characterized using ultraviolet-visible spectroscopy, x-ray diffraction spectroscopy, and transmission electron microscopy. Secondary metabolites were assessed using fourier transform infrared spectroscopy. Anti-oxidant potential was ascertained using 2,2-diphenyl-2-picrylhydrazyl hydrate (DDPH) assay and cytotoxicity of synthesized nanoparticles was evaluated on human liver cancer (Hep G2) and human embryonic kidney 293 (HEK-293T) cell lines. RESULTS: Synthesized ZnO-NP showed excellent antimicrobial properties against S. mutans, as the minimum inhibitory and bactericidal concentrations were 0.53 μg/mL, and 1.3 μg/mL respectively. ZnO-NP at 0.1 mg/μl concentration had the greatest zone of inhibition (24 mm), followed by 0.05 mg/μl ZnO-NP (23 mm) and 0.05 mg/μl ampicillin (21 mm). Further, 0.1 mg/μl ZnO-NP varnish inhibited 90 % of S. mutans biofilms and reduced 24 h acid production closest to that of baseline and it also exhibited antioxidant capacity in a dose dependent manner (94 % inhibition-100 μg/mL). Biocompatibility of ZnO-NP varnish was evaluated on Hep G2 and HEK-293T cell lines; and the highest concentration of 0.1 mg/μl ZnO-NP used caused very low cytotoxicity to Hep G2 cells and was non-cytotoxic to HEK-293T cells. CONCLUSIONS: Within the limits of this study, ZnO-NP varnish was effective in inhibiting S. mutans and holds great potential as an effective anticaries agent.
OBJECTIVE: Zinc is a potent antimicrobial against cariogenic bacteria and effective anti-plaque agent. The present study investigated the efficacy of zinc oxide nanoparticles (ZnO-NP) varnish to inhibit S. mutans growth, biofilm, acid production, and its antioxidant potential and cytotoxicity. DESIGN: Green synthesized ZnO-NP were characterized using ultraviolet-visible spectroscopy, x-ray diffraction spectroscopy, and transmission electron microscopy. Secondary metabolites were assessed using fourier transform infrared spectroscopy. Anti-oxidant potential was ascertained using 2,2-diphenyl-2-picrylhydrazyl hydrate (DDPH) assay and cytotoxicity of synthesized nanoparticles was evaluated on humanliver cancer (Hep G2) and humanembryonic kidney293 (HEK-293T) cell lines. RESULTS: Synthesized ZnO-NP showed excellent antimicrobial properties against S. mutans, as the minimum inhibitory and bactericidal concentrations were 0.53 μg/mL, and 1.3 μg/mL respectively. ZnO-NP at 0.1 mg/μl concentration had the greatest zone of inhibition (24 mm), followed by 0.05 mg/μl ZnO-NP (23 mm) and 0.05 mg/μl ampicillin (21 mm). Further, 0.1 mg/μl ZnO-NP varnish inhibited 90 % of S. mutans biofilms and reduced 24 h acid production closest to that of baseline and it also exhibited antioxidant capacity in a dose dependent manner (94 % inhibition-100 μg/mL). Biocompatibility of ZnO-NP varnish was evaluated on Hep G2 and HEK-293T cell lines; and the highest concentration of 0.1 mg/μl ZnO-NP used caused very low cytotoxicity to Hep G2 cells and was non-cytotoxic to HEK-293T cells. CONCLUSIONS: Within the limits of this study, ZnO-NP varnish was effective in inhibiting S. mutans and holds great potential as an effective anticaries agent.